vs

Side-by-side financial comparison of Instil Bio, Inc. (TIL) and 22nd Century Group, Inc. (XXII). Click either name above to swap in a different company.

22nd Century Group, Inc. is the larger business by last-quarter revenue ($3.5M vs $2.2M, roughly 1.6× Instil Bio, Inc.). 22nd Century Group, Inc. runs the higher net margin — -79.4% vs -365.3%, a 286.0% gap on every dollar of revenue. On growth, 22nd Century Group, Inc. posted the faster year-over-year revenue change (-12.0% vs -19.2%).

Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.

22nd Century Media was an American media company based in the suburbs of Chicago. The company was founded in 2005 and at one time published 14 weekly community newspapers. The publications had roughly 160,000 subscribers.

TIL vs XXII — Head-to-Head

Bigger by revenue
XXII
XXII
1.6× larger
XXII
$3.5M
$2.2M
TIL
Growing faster (revenue YoY)
XXII
XXII
+7.2% gap
XXII
-12.0%
-19.2%
TIL
Higher net margin
XXII
XXII
286.0% more per $
XXII
-79.4%
-365.3%
TIL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TIL
TIL
XXII
XXII
Revenue
$2.2M
$3.5M
Net Profit
$-8.2M
$-2.8M
Gross Margin
Operating Margin
-426.3%
-79.2%
Net Margin
-365.3%
-79.4%
Revenue YoY
-19.2%
-12.0%
Net Profit YoY
31.1%
38.4%
EPS (diluted)
$-1.13
$-36.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TIL
TIL
XXII
XXII
Q4 25
$2.2M
$3.5M
Q3 25
$2.2M
$4.0M
Q2 25
$2.2M
$4.1M
Q1 25
$2.2M
$6.0M
Q4 24
$2.8M
$4.0M
Q3 24
$1.5M
$5.9M
Q2 24
$0
$7.9M
Q1 24
$0
$6.5M
Net Profit
TIL
TIL
XXII
XXII
Q4 25
$-8.2M
$-2.8M
Q3 25
$-13.6M
$5.5M
Q2 25
$-21.4M
$-3.4M
Q1 25
$-28.2M
$-4.3M
Q4 24
$-11.9M
$-4.6M
Q3 24
$-23.0M
$-3.8M
Q2 24
$-14.9M
$-1.1M
Q1 24
$-24.3M
$-5.7M
Gross Margin
TIL
TIL
XXII
XXII
Q4 25
Q3 25
36.3%
Q2 25
29.9%
Q1 25
Q4 24
Q3 24
47.8%
Q2 24
51.3%
Q1 24
Operating Margin
TIL
TIL
XXII
XXII
Q4 25
-426.3%
-79.2%
Q3 25
-670.0%
-80.1%
Q2 25
-1045.5%
-73.0%
Q1 25
-1363.2%
-43.1%
Q4 24
-426.1%
-101.8%
Q3 24
-1582.8%
-56.8%
Q2 24
-25.8%
Q1 24
-68.5%
Net Margin
TIL
TIL
XXII
XXII
Q4 25
-365.3%
-79.4%
Q3 25
-606.0%
136.8%
Q2 25
-954.2%
-83.4%
Q1 25
-1257.8%
-72.7%
Q4 24
-428.8%
-113.3%
Q3 24
-1541.9%
-63.2%
Q2 24
-14.0%
Q1 24
-88.7%
EPS (diluted)
TIL
TIL
XXII
XXII
Q4 25
$-1.13
$-36.48
Q3 25
$-2.01
$-0.28
Q2 25
$-3.24
$-13.61
Q1 25
$-4.32
$-2.50
Q4 24
$-1.82
$-42962.00
Q3 24
$-3.54
$-1760.26
Q2 24
$-2.29
$-593.72
Q1 24
$-3.74
$-395.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TIL
TIL
XXII
XXII
Cash + ST InvestmentsLiquidity on hand
$6.6M
$7.1M
Total DebtLower is stronger
$708.0K
Stockholders' EquityBook value
$113.9M
$15.8M
Total Assets
$203.5M
$27.0M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TIL
TIL
XXII
XXII
Q4 25
$6.6M
$7.1M
Q3 25
$5.8M
$4.8M
Q2 25
$7.7M
$3.1M
Q1 25
$15.4M
$1.1M
Q4 24
$8.8M
$4.4M
Q3 24
$6.7M
$5.3M
Q2 24
$6.8M
$1.3M
Q1 24
$5.5M
$1.5M
Total Debt
TIL
TIL
XXII
XXII
Q4 25
$708.0K
Q3 25
Q2 25
$3.2M
Q1 25
$3.9M
Q4 24
$6.7M
Q3 24
$7.0M
Q2 24
$7.5M
Q1 24
$14.7M
Stockholders' Equity
TIL
TIL
XXII
XXII
Q4 25
$113.9M
$15.8M
Q3 25
$120.4M
$18.4M
Q2 25
$131.7M
$5.6M
Q1 25
$144.9M
$3.6M
Q4 24
$169.4M
$4.0M
Q3 24
$176.3M
$3.5M
Q2 24
$195.0M
$-955.0K
Q1 24
$205.8M
$-11.6M
Total Assets
TIL
TIL
XXII
XXII
Q4 25
$203.5M
$27.0M
Q3 25
$211.8M
$32.4M
Q2 25
$231.0M
$22.4M
Q1 25
$237.4M
$21.5M
Q4 24
$263.6M
$21.7M
Q3 24
$272.6M
$26.2M
Q2 24
$294.3M
$24.1M
Q1 24
$306.3M
$24.6M
Debt / Equity
TIL
TIL
XXII
XXII
Q4 25
0.04×
Q3 25
Q2 25
0.57×
Q1 25
1.08×
Q4 24
1.66×
Q3 24
2.02×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TIL
TIL
XXII
XXII
Operating Cash FlowLast quarter
$-7.1M
$2.7M
Free Cash FlowOCF − Capex
$2.7M
FCF MarginFCF / Revenue
77.3%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TIL
TIL
XXII
XXII
Q4 25
$-7.1M
$2.7M
Q3 25
$-10.6M
$-4.0M
Q2 25
$-14.8M
$-3.5M
Q1 25
$-4.2M
$-3.0M
Q4 24
$-10.6M
$-4.4M
Q3 24
$-20.1M
$-3.0M
Q2 24
$-10.6M
$-4.7M
Q1 24
$-14.4M
$-2.3M
Free Cash Flow
TIL
TIL
XXII
XXII
Q4 25
$2.7M
Q3 25
$-4.0M
Q2 25
$-3.5M
Q1 25
$-3.0M
Q4 24
Q3 24
$-3.0M
Q2 24
$-4.8M
Q1 24
$-2.3M
FCF Margin
TIL
TIL
XXII
XXII
Q4 25
77.3%
Q3 25
-100.3%
Q2 25
-85.9%
Q1 25
-50.1%
Q4 24
Q3 24
-51.2%
Q2 24
-60.1%
Q1 24
-35.0%
Capex Intensity
TIL
TIL
XXII
XXII
Q4 25
0.5%
Q3 25
0.1%
Q2 25
0.7%
Q1 25
0.2%
Q4 24
0.0%
0.0%
Q3 24
0.0%
1.2%
Q2 24
0.8%
Q1 24
0.1%
Cash Conversion
TIL
TIL
XXII
XXII
Q4 25
Q3 25
-0.73×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons